BR100 Decreased By (-0.37%)
BR30 Decreased By (-0.27%)
KSE100 Decreased By (-0.34%)
KSE30 Decreased By (-0.42%)
AGHA 7.74 Decreased By ▼ -0.07 (-0.9%)
BECO 5.18 Decreased By ▼ -0.03 (-0.58%)
BML 57.58 Increased By ▲ 0.08 (0.14%)
BOP 34.20 Increased By ▲ 0.17 (0.5%)
CNERGY 10.15 Increased By ▲ 0.19 (1.91%)
CSIL 5.30 Decreased By ▼ -0.01 (-0.19%)
FCCL 54.20 Decreased By ▼ -0.50 (-0.91%)
FFL 16.60 Decreased By ▼ -0.09 (-0.54%)
FNEL 1.23 No Change ▼ 0.00 (0%)
KEL 7.29 Decreased By ▼ -0.11 (-1.49%)
KOSM 5.77 No Change ▼ 0.00 (0%)
LOTCHEM 29.39 Increased By ▲ 0.07 (0.24%)
MLCF 93.30 Decreased By ▼ -1.06 (-1.12%)
NBP 202.00 Decreased By ▼ -1.05 (-0.52%)
NCPL 57.00 No Change ▼ 0.00 (0%)
NPL 67.40 Decreased By ▼ -0.30 (-0.44%)
OGDC 315.25 Decreased By ▼ -0.59 (-0.19%)
PACE 10.64 No Change ▼ 0.00 (0%)
PAEL 42.99 Decreased By ▼ -0.21 (-0.49%)
PIBTL 16.62 Decreased By ▼ -0.12 (-0.72%)
PPL 218.84 Decreased By ▼ -0.94 (-0.43%)
PRL 51.71 Increased By ▲ 2.52 (5.12%)
PTC 70.40 Decreased By ▼ -0.13 (-0.18%)
SSGC 27.58 Decreased By ▼ -0.67 (-2.37%)
TBL 9.79 Decreased By ▼ -0.07 (-0.71%)
TELE 8.72 Decreased By ▼ -0.07 (-0.8%)
TPL 18.59 Increased By ▲ 0.35 (1.92%)
TPLP 13.61 Increased By ▲ 0.34 (2.56%)
TREET 22.61 Decreased By ▼ -0.11 (-0.48%)
TRG 60.15 Increased By ▲ 0.01 (0.02%)

ISLAMABAD: Federal Minister for Finance and Revenue Miftah Ismail has directed the relevant authorities to undertake the required measures for addressing the concerns of the pharmaceutical industry.

During a meeting with the representatives of the Pakistan Pharmaceutical Industry on Monday, the minister was briefed about the contribution of the pharmaceutical industry in the economic development of the country.

The matters related to sales tax on import of raw materials and refunds of sales tax faced by the pharmaceutical industry in Pakistan were also discussed in the meeting.

Ismail acknowledged the contribution of the pharmaceutical industry and stressed that the present government is committed to resolving the operational issues being faced by various sectors of the economy.

He further assured the delegation to resolve the issues faced by the pharmaceutical industry at the earliest.

The government side in the meeting was represented by ShahidKhaqanAbbasi, Bilal Kiyani,coordinator to the Prime Minister on economy, Rana Ihsan Afzal, coordinator to the Prime Minister on Commerce and Industry, the chairman Federal Board of Revenue (FBR) while the pharmaceutical industry was represented by CEO GSK ErumShakir Rahim, CEO Ferozsons Osman Waheed, MD Abbott Anis Ahmed, CEO SanteTauqeerulHaq, ED Pharma Bureau Ayesha Tammy Haq, and senior officers from the FBR and the Finance Division attended the meeting.

Copyright Business Recorder, 2022

Comments

Comments are closed for this article.